DAFNA Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Buy |
238,140
+55,000
| +30% | +$721K | 0.86% | 28 |
|
|
2025
Q1 | $4.03M | Sell |
183,140
-4,000
| -2% | -$88K | 1.14% | 25 |
|
|
2024
Q4 | $5M | Sell |
187,140
-40,766
| -18% | -$1.09M | 1.27% | 22 |
|
|
2024
Q3 | $6.08M | Sell |
227,906
-62,291
| -21% | -$1.66M | 1.44% | 21 |
|
|
2024
Q2 | $5.23M | Sell |
290,197
-16,000
| -5% | -$288K | 1.25% | 24 |
|
|
2024
Q1 | $5.59M | Sell |
306,197
-143,187
| -32% | -$2.61M | 1.27% | 24 |
|
|
2023
Q4 | $4.92M | Sell |
449,384
-70,000
| -13% | -$766K | 1.18% | 27 |
|
|
2023
Q3 | $2.98M | Hold |
519,384
| – | – | 0.93% | 31 |
|
|
2023
Q2 | $4.03M | Sell |
519,384
-213,855
| -29% | -$1.66M | 1.1% | 28 |
|
|
2023
Q1 | $4.89M | Sell |
733,239
-33,604
| -4% | -$224K | 1.47% | 23 |
|
|
2022
Q4 | $6.86M | Sell |
766,843
-14,269
| -2% | -$128K | 1.93% | 16 |
|
|
2022
Q3 | $7.69M | Buy |
781,112
+85,153
| +12% | +$838K | 2.07% | 15 |
|
|
2022
Q2 | $5.54M | Buy |
695,959
+339,209
| +95% | +$2.7M | 1.51% | 20 |
|
|
2022
Q1 | $3.46M | Buy |
+356,750
| New | +$3.46M | 0.9% | 32 |
|